China Universal Asset Management Company’s Spyre Therapeutics SYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$181K	Buy	12,122 +35	+0.3%	+$524	0.02%	318
2025 Q1	$195K	Sell	12,087 -353	-3%	-$5.7K	0.02%	314
2024 Q4	$290K	Buy	+12,440	New	+$290K	0.03%	298
2022 Q4	–	Sell	-23	Closed	–	–	462
2022 Q3	$0	Buy	+23	New	–	﹤0.01%	462